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Abstract COUP-TF family orphan receptors regulate activity 
of ligand-aetivated nuclear hormone receptors or function 
independently in the regulation of gene expression. COUP-TF 
II has a complex expression pattern suggesting that different 
mechanisms are involved in the regulation of its expression. We 
isolated the 5' regulatory region of the mouse COUP-TF II gene 
and demonstrated that the basal promoter is localized in a -200 
bp region 5' from the transcription start site. AIl-trans retinoic 
acid and dibutyryl cyclic AMP have cell type specific effects on 
COUP-TF II promoter activity. The effect of cyclic AMP is 
mediated by the cyclic AMP response lement hat is localized 74 
nucleotides upstream from the major transcriptional start. In 
vitro promoter analyses also demonstrated that the effect of all- 
trans RA is not directly mediated by the binding of RARs or 
RXRs to the promoter sequence. 
Key words: COUP-TF II; Gene regulation; Promoter; 
Retinoic acid; Dibutyryl cyclic AMP 
1. Introduction 
Nuclear hormone receptors play an important role during 
development of different cell types and organ systems [1,2]. 
Retinoic acid (RA) receptors, retinoid X receptors, thyroid 
hormone receptors, steroid hormone receptors, and several 
other members of the superfamily of nuclear hormone recep- 
tors regulate expression of a variety of target genes [3,4]. 
These ligand dependent transcription factors bind as homo- 
or heterodimers to hormone response lements (HRE) located 
in the regulatory regions of target genes and regulate tran- 
scription [3]. Recently, it has been shown that nuclear hor- 
mone receptors can also suppress transcriptional ctivity by 
complexing with non DNA binding co-repressors [5-8]. Beside 
the ligand activated transcription factors, the nuclear hor- 
mone receptor superfamily comprises orphan receptors for 
which ligands are not known [9,10]. Orphan receptors, such 
as chicken ovalbumin upstream promoter transcription factor 
(COUP-TF) homologs, have been isolated from several spe- 
cies including rodents and human [11-21]. COUP-TF orphan 
receptors function as transcriptional ctivators or suppressors 
depending on the complexes they form and DNA sequences 
on which they bind. One function of the COUP-TFs is to 
regulate the activity of ligand activated nuclear hormone re- 
ceptors [22,23]. Several different mechanisms may contribute 
to the repression of induction including direct competition of 
COUP-TFs for the hormone response lements, heterodimer- 
ization with retinoid X receptors (RXR) and suppression of 
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transcription by COUP-TF homodimers [22,24-27]. Repres- 
sion by COUP-TFs may also sensitize promoters of different 
genes to positively acting nuclear hormone receptors [26]. 
COUP-TFs may also function as a stimulatory transcription 
factors. COUP-TFs stimulate transcription of arrestin gene by 
binding to a direct repeat with a 7 bp spacer located upstream 
of the transcription start site [28]. In combination with HNF-4 
transcription factor, COUP-TF I and COUP-TF II may also 
stimulate transcription of the phosphoenolpyruvate carboxy- 
kinase gene [29]. 
Complex expression patterns of COUP-TF I (Ear-3) and 
COUP-TF II (ARP-1) during development argue for their 
functional roles in several developmental processes. While 
the potential functions of COUP-TFs have been extensively 
investigated, the molecular mechanisms responsible for the 
spatial and temporal expression of COUP-TFs are still poorly 
understood. Expression of COUP-TFs in different regions of 
developing and adult organisms indicates that different mech- 
anisms are involved in the regulation of their spatial and 
temporal expression. 
Here we demonstrate hat COUP-TF II basal promoter is 
localized in the 200 bp region 5' from the transcription start 
site, and that all-trans retinoic acid and dibutyryl cyclic AMP 
have cell type specific effects on COUP-TF II promoter activ- 
ity. Also, COUP-TF I and COUP-TF II weakly inhibit RA 
induced COUP-TF II promoter activity in PCC7 cells. 
2. Materials and methods 
2.1. Plasmid construction 
A mouse genomic DNA library (Clontech) was screened with 
mouse COUP-TF II cDNA probe (isolated in our laboratory) using 
high stringency conditions (0.1 X SSC, 65°C; 1 X SSC = 150 mM NaC1, 
15 mM Na-citrate). Fragments of isolated clones were subcloned into 
Bluescript II KS plasmid (Stratagene) for sequencing and generation 
of promoter constructs. All the COUP-TF II promoter fragments 
were cloned into the unique BgllI site of the vector pCAT3N using 
BgllI linkers. COUP-TF II promoter fragments of various lengths 
were generated by digestion of 5' regulatory region DNA with endo- 
nucleases listed below: for plasmid -40001BgllI with BamHI and 
BglIl, for -15001BgllI with HindlII and BgllI, for --621/BgllI with 
BstXI and BgllI, for -320/ApaI with ApaI, for -971ApaI with StyI 
and ApaI, for -320/Sacli with ApaI and SaclI, for -40/SaclI with 
SacI and SaclI, for -40/Apal with SacI and ApaI, and for SaclIIApaI 
with SaclI and ApaI. Constructs -2581ApaI and -2001ApaI were 
generated by digestion of ApaI fragment with Exonuclease III. Con- 
struct AStylIApaI was generated by deletion of StyI fragment from 
the -3201ApaI plasmid. 
Site directed mutagenesis was performed using plasmid --3201ApaI 
and oligonucleotides 5'-GTTGCAGCAGTCGTGATGCATTTCAC- 
TATATAGAGAG (mut 1) and 5'-ACGTGCGCTAAGTTGCA- 
TATGTCGTGTCAAAGTTCACT (mut 3). Erase-a-Base System 
(Promega) was used to generate mutations mut 2 and mut 4 by digest- 
ing plasmids mut 1 and mut 3 with NsiI and NdeI, respectively. 
Mouse COUP-TF I and COUP-TF II (cloned in our laboratory) 
cDNAs were cloned into eukaryotic expression vector pRcCMV-neo 
(Invitrogen) using appropriate r striction endonucleases. 
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BstXI 
TSGTTTGCAAGCCCAGATCCCGGCACCTTGCCACCTCCGCTGCGTACCCCTCTACAAAGA -562 
AGGGGAGAGCATTATTCAGTCTTTTGGAATAGTGGGTTCTACATAATGCGCCGGGAGTCC -502 
CGGTGGACCGCGAGCTCGCATTTAGAGGCATCGCAAGTTGCGAGAGACTAAGTCTTTGGC -442 
TCCATCCTCAACCCCTTGCGGACGCTTTAAGAGTCGTAGTGTGTGCGCCGCACTAGTCTT -382 
GCGCAGGGCGGAAACCACTGTGCCGATGCGGCGGCGGGGTCCGCGCTCGGCTGCCACCGG -322 
ApaI 
GCC¢CCATCCCCCTCTCTGTGGCCAGGACCGCGCGGCCACCCGTCCCCGCCCCCCTCCGT -262 
CCCCGCGCGCCCCGTGCGCTTGTCTCGACGCCGCTCGCGCTAGGACCGGGCTGCTCCCGC -202 
StyI 
TGCCGCCATGGCGGGCCGCTGCGCTCCGGCCAATGACGACGAGGGGGCGGCGCGCGCGCG -142 
StyI 
CGGCCGGGCCAACCCCGGCGGCTGCCTTATAAGGCGGCCCGTCGCCATGGCAACGTGCGC -82 
* * SacI * * 
TAAGTTGCAGCAGTCGTGTCAAAGTTCACTATATAGAGAGCTCAGTGAGTGATCGAGGAG -22 
AAGCAACTTCTGCCAGCCCGGAGCCTATAAATCGCATTCCCTCCCGAGCCCCCCTTTTTA 37 
SacII 
GCATATTTGATCACTTTGATTCTGCTCTTTTCTCTCCGCGGTGTGTGCGTCGGTGCGCGC 97 
GTGTGTGTTTTCTTCTCCTCCTCCTCCTCTGCGAGTTGCCTCCTTTCTCCGGGTGCGGCT 157 
GCTCTTCCCTCTTTCATTCTTTCTCTCCGTTTCTCCCCCCTCTGCGCACGAAGGATGCGC 217 
TTCTAGGTGCTGATCTGCCCTCCTTTCTCTCTTATCATCTCTCCCGCCGCCGGCGAGTTG 277 
ACTCTTTCCCTATTGCTGCTTGAGGTGTGCGGCAGCAGCAGCAGCAGCAGCAGCAGCAGC 337 
GGCTCCACCGGCGGCGGCAGCAGCGGCAGCAGCAGCAGCGACTCCACCGGGGACGGCGGG 397 
ApaI 
TAGACGCAGCGGCTCCGGGCCC 
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Fig. 1. Nucleotide sequence of the mouse COUP-TF II 5' regulatory region (A) and its promoter activity in mouse embryo carcinoma PCC7, 
mouse fibroblast 3T3, and human cervical carcinoma C33A cells (B). (A) Nucleotide numbering starts at the major transcriptional start site (1), 
upstream nucleotides have negative numbers. Minor start sites are indicated by * (above the corresponding ucleotides). The TATA-box core 
motifs are indicated by boldface letters, and restriction sites used in generation of CAT constructs are indicated. (B) In the schematic represen- 
tation of mCOUP-TF II promoter egion restriction sites and major start site (arrow) are indicated. The data shown are representative of at 
least three independent CAT assays. 
2.2. Cell culture and grown in Dulbecco's modified Eagle's medium (Gibco) containing 
Embryonic arcinoma cell line PCC7 was obtained from S. Pfeiffer 10% fetal bovine serum (Summit Biotechnology). PCC7 cells were 
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Fig. 2. Effects of all-trans retinoic acid and dibutyryl cAMP on COUP-TF II promoter activity in CAT assay 
PCC7 cells. Cells were treated with all-trans RA (0.5 [tM), dBcAMP (1 mM) or combination of all-trans RA 
are representative of at least three independent experiments. 
using mouse embryo carcinoma 
and dBcAMP. The data shown 
differentiated into neuronal-like c lls with all-trans RA (0.5 p,M) and 
dibutyryl cyclic AMP (dBcAMP; 1 mM) treatment. Mouse fibroblast 
3T3, rat glioblastoma C6, human glioblastoma U373, and human 
cervical carcinoma C33A cells were obtained from the American 
Type Culture Collection and were grown in Dulbecco's modified 
Eagle's medium supplemented with 10% fetal bovine serum. 
2.3. DNA transfection and CAT assays 
Cells were transfected with 15 p.g of total plasmid DNA, using the 
calcium phosphate precipitation method [30] in 60 mm diameter 
dishes (1 x l0 ~ to 3x10 ~ cells per dish). The medium was changed 
12-18 h after transfection to normal growth medium or medium con- 
taining all-trans RA (5 X 10 7 M) or dBcAMP (1 mM) as indicated 
for each experiment. Ceils were harvested 48 h later. Cells were 
washed and harvested in PBS, lysed in 150 lal of 0.25 M Tris-HC1 
(pH 7.6) by freeze/thawing three times, and incubated at 65°C for 10 
min to minimize deacylation activity. Protein concentration i the 
lysates was determined by a protein assay reagent (Pierce Chemical 
Co.) with BSA used as a standard. A 150 /.tl mixture containing 
0.4 mM acetyl coenzyme A, 0.1 ktCi of [dichloroacetyl-l,2- 
14C]chloramphenicol, and 10-25 ktg of protein was incubated at 
37°C for 0.5-1.5 h. After extraction with ethyl acetate, the radioactive 
forms of chloramphenicol were resolved by thin-layer chromatogra- 
phy. Quantitation of acetylation ratios was obtained by PhosphorI- 
mager (Molecular Dynamics) analysis. To normalize transfection effi- 
ciencies, cells were cotransfected with 1 p.g of plasmid pRcRSVlacZ. 
All the reported CAT activities were normalized to total protein and 
lacZ activity. The CAT assay values represent the means of at least 
three independent transfections. 
3. Results 
3.1. Analysis of COUP-TF H gene promoter egion 
We isolated a phage clone containing the 5' end of the 
COUP-TF II gene and sequenced a 1.5 kb fragment hat ex- 
tended for 622 nucleotides upstream of the major transcrip- 
tion initiation site (Fig. 1A). The transcription i itiation sites 
were mapped by primer extension and RNase protection ana- 
lyses (data not shown) using RNA isolated from embryonic 
day 11, 13, and 15 mouse embryos. Both methods demon- 
strated the presence of several transcription start sites (Fig. 
1). The sequence of the 5'-proximal region contains several 
consensus TATA box sequences in the region where all the 
transcription start sites are localized (Fig. 1A). TATA box 
sequences in COUP-TF II promoter do not lie at typical dis- 
tances (20-30 nucleotides) from start sites which is not an 
unusual situation. 
To determine the sequences that are essential for transcrip- 
tion of mouse COUP-TF II gene, various portions of the 5'- 
flanking region were fused to the bacterial chloramphenicol 
acetyltransferase (CAT) gene as a heterologous reporter gene. 
Reporter plasmids containing different fragments of the 
COUP-TF II gene 5' region (Fig. 1B) were transiently trans- 
fected into the mouse teratocarcinoma PCC7, mouse fibro- 
blast 3T3, and human cervical carcinoma C33A cells. CAT 
assays demonstrated that COUP-TF II promoter CAT plas- 
mids -4000lBglII, - 1500lBglII, -6211BglII, - 3201ApaI, 
-2581ApaI, -200/ApaI, and -3201SacII have similar promo- 
ter activity in all studied cell lines (Fig. 1B). Deletion of addi- 
tional 103 nucleotides (construct -971ApaI) resulted in 4-6- 
fold reduction of promoter activity. Also, deletion of nucleo- 
tides -196  to -97  from -3201ApaI construct (plasmid AStyII 
ApaI) resulted in 2-3-fold reduction of promoter activity. 
CAT constructs containing 40 bp promoter sequences (con- 
structs -40lSacII and -40lApaI) and first exon sequences 
(construct SacII/ApaI) showed almost no CAT activity. This 
deletion analysis demonstrated that the COUP-TF II basal 
promoter is localized in the 200 bp region 5' from the tran- 
scription start site. 
3.2. All-trans retinoic acid and cAMP induce COUP-TF H 
promoter activity in teratocarcinoma PCC7 cells and sup- 
press it in C6 and U373 glioma cells 
Since COUP-TF II is involved in the modulation of retinoic 
acid responses and may function as a part of the regulatory 
loop, we analyzed the effect of all-trans RA on the activity of 
its promoter. Initially, we used teratocarcinoma PCC7 cells 
which have been shown to express all three RAR and RXR 
genes [31]. Also, RA treatment induces expression of all three 
RAR genes in these cells ([31] and our unpublished ata). 
CAT assays following transient transfection by COUP-TF II 
promoter-CAT plasmids containing different fragments of 5' 
regulatory region (-40001BglII, -1500/BglII, -6211BglII, 
--320/ApaI, --200/ApaI, --971ApaI, --40lApaI, and SacIII 
ApaI) demonstrated that RA treatment induces promoter ac- 
tivity of all plasmids which contain more than 40 bp of the 
promoter egion (Fig. 2). These CAT assay data suggest hat 
RA response lement(s) are localized in the --97 to -40  nu- 
cleotide promoter egion. Increased levels of cAMP have been 
shown to potentiate the effect of RA on neuronal differentia- 
tion in teratocarcinoma cells (our unpublished data). Based on 
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Fig, 3. Effects of mutations in CRE and HRE on mCOUP-TF II 
promoter activity. (A) Nucleotide sequences of wild type and mu- 
tated (mut 1, mut 2, mut 3, mut 4; changed nucleotides are in lower 
case) promoter regions. (B) Effect of all-trans retinoic acid and di- 
butyryl cAMP on wild type and mutated COUP-TF II promoter ac- 
tivity in transient CAT assay using mouse embryo carcinoma PCC7 
cells. The wild type -3201ApaI CAT plasmid and mutated reporter 
plasmids, rout 1, rout 2, mut 3, and mut 4 were transfected into 
PCC7 cells and cells were treated with all-trans RA (0.5 gM), 
dBcAMP (1 raM) or combination of all-trans RA and dBcAMP. 
The data shown are representative of at least three independent ex- 
periments. 
these observations, we also analyzed the effect of dibutyryl 
cAMP (dBcAMP) on COUP-TF II promoter activity in ter- 
atocarcinoma PCC7 cells. The same promoter CAT constructs 
that responded to the RA treatment were also responsive to 
dBcAMP treatment (Fig. 2). This argues that cAMP response 
element(s) are localized in -97  to -40  bp region of COUP- 
TF II promoter. Cotreatment of PCC7 cells with RA and 
dBcAMP stimulated COUP-TF II promoter activity about 
15-20-fold. 
Sequence analyses of -97  to -40  bp COUP-TF II promo- 
ter region revealed a cAMP response lement (CRE) and a 
possible consensus equence for hormone response element 
(HRE) localized next to each other (Fig. 3). Mutations were 
introduced into these elements to assess their functionality 
(Fig. 3). COUP-TF II 320 bp promoter CAT plasmids 
(-320/ApaI CAT) containing mutated CRE and FIRE were 
transfected into PCC7 cells, and effects of RA and dBcAMP 
on promoter activity were analyzed. Surprisingly, mutations 
which destroyed HRE (rout 1 and mut 2) did not affect in- 
ducibility of COUP-TF II promoter activity (Fig. 3). How- 
ever, mutations in CRE (mut 3) or in both CRE and HRE 
together (rout 4) completely blocked the effect of dBcAMP on 
the inducibility of the promoter. These results argue that RA 
has an indirect effect on COUP-TF II promoter activity in 
PCC7 cells. Also, the additive effect of RA and dBcAMP 
suggests that RA and dBcAMP have different pathways to 
stimulate COUP-TF II promoter activity. 
To further explore the role of RA on COUP-TF II promo- 
ter activity, we performed CAT assays using mouse fibroblast 
3T3, rat glioblastoma C6, human glioblastoma U373, and 
human cervical carcinoma C33A cells. Treatment of 3T3 
and C33A cells with RA and dBcAMP did not affect the 
activity of COUP-TF II promoter constructs -320/ApaI and 
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-4000/BgllI (Fig. 4A,B). On the other hand, both RA and 
dBcAMP suppressed activity of COUP-TF II promoter con- 
structs in C6 and U373 cells. 
3.3. COUP-TF I and COUP-TF H weakly inhibit RA induced 
COUP-TF H promoter activity in PCC7 cells 
Transcription factors COUP-TF I and COUP-TF II block 
the stimulatory effect of RA on transcription of several genes 
[24-27]. Our data demonstrate hat RA induces COUP-TF II 
promoter activity in PCC7 cells. We then asked whether 
COUP-TF I and COUP-TF II block the stimulatory effect 
of RA on COUP-TF II promoter activity. We cotransfected 
the -320/ApaI COUP-TF II CAT construct with COUP-TF I 
and COUP-TF II expression plasmids into PCC7 cells and 
analyzed CAT activities. As a positive control, we used a 
plasmid containing an RARI]2 promoter lacZ construct 
(from A. Zimmer, NIH) that has been shown to be inducible 
with activated RARs and RXRs. CAT assays demonstrated 
that both COUP-TF I and COUP-TF II slightly suppress RA 
and dBcAMP induced COUP-TF II promoter activity (Fig. 
4C). By contrast, COUP-TF I and COUP-TF II completely 
inhibit the RA and dBcAMP induced RARI32 promoter ac- 
tivity (Fig. 4C). This is an additional indication that RA does 
not directly regulate COUP-TF II promoter activity through 
activation of RAR/RXR complexes. 
4. Discussion 
The central issue addressed in this study is the transcrip- 
tional regulation of the COUP-TF II gene. COUP-TF II gene 
is expressed in a complex spatio-temporal pattern during de- 
velopment of several organ systems including nervous system 
[19-21,32]. This complex expression pattern argues for a dif- 
ferent mechanisms of COUP-TF II gene regulation in differ- 
ent cell types. Our data demonstrate that the effects of RA 
and dBcAMP on the COUP-TF II promoter activity are dif- 
ferent or even opposite in different cell types. Also, treatment 
of mouse embryos with all-trans RA results in stimulation of 
COUP-TF II expression i  the spinal cord and suppression of 
expression in the telencephalon [33]. Additionally, it has been 
demonstrated that expression of COUP-TF I and COUP-TF 
II is induced during neuronal differentiation of teratocarcino- 
ma P19 cells [19,32] but not in several other teratocarcinomas 
(our unpublished ata). Our data support he hypothesis that 
COUP-TF II gene expression is regulated ifferently in differ- 
ent cell types and that the same stimuli may regulate its ex- 
pression in opposite directions depending on the cell type. 
Analyses of COUP-TF II promoter activity localized the 
functional cAMP response lement 74 nucleotides upstream 
from the major transcriptional start site. This CRE is respon- 
sible for the stimulatory effect of dBcAMP in teratocarcinoma 
PCC7 cells. The suppressive effect of dBcAMP on COUP-TF 
II promoter activity in C6 and U373 cells is not mediated by 
the same CRE since mutation in this sequence or deletion of it 
does not change the response of COUP-TF II promoter to 
dBcAMP in these cells. Sequence analyses of COUP-TF II 
promoter also identified a possible HRE localized 68 nucleo- 
tides from the major transcriptional start site. The sequence of 
this element does not correspond exactly to HRE, but con- 
sidering the high variability of HRE sequences, it is possible 
that this sequence functions as a binding site for RARs or 
RXRs. Also, CAT assays mapped the RA response lement to 
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Fig. 4. Effects of all-trans retinoic acid, dibutyryl cAMP (A and B), 
and COUP-TF I and COUP-TF II (C) on COUP-TF II promoter 
activity in CAT assay using mouse fibroblast (3T3), rat glioblastoma 
(C6), human glioblastoma (U373), human cervical carcinoma 
(C33A), and mouse teratocarcinoma (PCC7) cells. (A and B) Mouse 
COUP-TF II -4000/BgllI (A) and -320/ApaI (B) CAT plasmids 
were transfected into 3T3, C6, U373, and C33A cells. Cells were 
treated with all-trans RA (0.5 IxM), dBcAMP (1 mM) or combina- 
tion of all-trans RA and dBcAMP and CAT activities were meas- 
ured. Left side scale represents CAT activity for 3T3, C6, and U373 
cells and right side scale for C33A cells. (C) Mouse COUP-TF II 
promoter eporter plasmids -4000/BgllI, -3201ApaI and RARI3-2- 
lacZ reporter plasmid were cotransfected with expression plasmid 
pRcCMVneo without any cDNA (control and dBcAMP+RA) or 
containing mCOUP-TF I (dBcAMP+RA+COUP-TF I) or mCOUP- 
TF II (dBcAMP+RA+COUP-TF II) cDNA into PCC7 cells. Cells 
were treated with all-trans RA (0.5 ~M) and dBcAMP (1 mM) and 
CAT and lacZ activities were measured. Left side scale represents 
CAT activity for --40001BgllI and -3201ApaI constructs and right 
side scale represents lacZ activity for for RAR~-2-lacZ construct. 
The data shown are representative of at least three independent ex- 
periments. 
the region -97 to -40. The putative HRE localized 68 nu- 
cleotides from the major start site is the only sequence that 
has certain homology to HRE in this region. Mutations in this 
HRE or deletion of this sequence do not affect inducibility of 
COUP-TF II promoter activity by RA. Also, coexpression of
COUP-TF I or COUP-TF II, which completely blocks RA 
inducibility of RARe2 promoter activity, only slightly reduces 
RA inducibility of COUP-TF II promoter activity. These data 
suggest hat the effect of RA on COUP-TF II promoter ac- 
tivity is not directly mediated by the binding of RARs or 
RXRs to the response lement, but is indirect. This hypothesis 
is supported by the data which demonstrate that the induction 
of the COUP-TF II gene expression by RA in teratocarcino- 
ma P19 cells is a relatively slow process. Induction of COUP- 
TF II gene expression occurs 24-40 h after treatment of P19 
cells with all-trans or 9-cis retinoic acid [19,34]. In contrast, 
induction of genes that are directly regulated by the RARs or 
RXRs, for example RARI3 and midkine [31,35,36], occurs in 
less than 5 h. 
Analyses of COUP-TF II promoter activity in different cell 
lines revealed that all-trans RA either stimulates, uppresses 
or has no effect on transcription. These results suggest hat 
COUP-TF II is involved at least in two different functions of 
retinoids. First, in cells where COUP-TF II promoter activity 
is stimulated by retinoids, it may function as a part of the 
negative feedback loop to suppress effects of retinoids. Sec- 
ond, in cells where COUP-TF II promoter activity is sup- 
pressed by retinoids, the retinoid response may be long last- 
ing. At the same time, COUP-TF II may also be involved in 
timing the switches of retinoic acid mediated gene regulation. 
Detailed analyses of regulation of COUP-TF II expression i  
different cell types, and characterization f its role in cell type 
specific gene regulation are required to understand the logic of 
COUP-TF II functioning during development and in the adult 
organisms. 
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